Literature DB >> 33552608

Vogt-Koyanagi-Harada Disease: A Case Series in a Tertiary Eye Center.

Pranav Shrestha1, Sadhana Sharma1, Ranju Kharel2.   

Abstract

PURPOSE: To study the clinical spectrum of Vogt-Koyanagi-Harada (VKH) disease in a tertiary eye center in Nepal.
METHODS: Baseline demographic details and clinical features of six patients diagnosed as VKH in a tertiary eye center were retrospectively reviewed. Examinations included best corrected visual acuity, intraocular pressure, and slit lamp examination of anterior and posterior segments. Baseline blood investigations, chest X-ray, fundus photography, and fundus fluorescent angiography (FFA) were performed on all the patients.
RESULTS: The mean age at presentation was 46 ± 8.43 years with female predominance (83.3%). The disease was complete in 16.7%, incomplete in 16.7%, and probable in 66.7% of the patients. Most cases presented in acute uveitis stage (66.7%). The most common finding in acute cases was serous retinal detachment (66.7%), followed by disc edema (58.3%), whereas in chronic cases, depigmented fundus was the most common. All cases had bilateral presentation.
CONCLUSION: VKH is an important cause of bilateral loss of vision and has a good visual prognosis if aggressive treatment is initiated during the early stages.
Copyright © 2021 Pranav Shrestha et al.

Entities:  

Year:  2021        PMID: 33552608      PMCID: PMC7847319          DOI: 10.1155/2021/8848659

Source DB:  PubMed          Journal:  Case Rep Ophthalmol Med


  11 in total

1.  Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy.

Authors:  I Paredes; M Ahmed; C S Foster
Journal:  Ocul Immunol Inflamm       Date:  2006-04       Impact factor: 3.070

2.  Unilateral vogt-koyanagi-harada disease: report of two cases.

Authors:  Alok Agrawal; Jyotirmay Biswas
Journal:  Middle East Afr J Ophthalmol       Date:  2011-01

Review 3.  Vogt-Koyanagi-Harada syndrome.

Authors:  R S Moorthy; H Inomata; N A Rao
Journal:  Surv Ophthalmol       Date:  1995 Jan-Feb       Impact factor: 6.048

4.  Presumed Vogt-Koyanagi-Harada disease with unilateral ocular involvement: report of three cases.

Authors:  Yoshihiko Usui; Hiroshi Goto; Jun-ichi Sakai; Masaru Takeuchi; Masahiko Usui; Narsing A Rao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-03-24       Impact factor: 3.117

5.  Variations in clinical features of the Vogt-Koyanagi-Harada syndrome.

Authors:  J Beniz; D J Forster; J S Lean; R E Smith; N A Rao
Journal:  Retina       Date:  1991       Impact factor: 4.256

6.  Diagnostic Value of Optical Coherence Tomography in the Early Diagnosis of Macular Complications in Chronic Vogt-Koyanagi-Harada Disease.

Authors:  Mamta Agarwal; Aleksandra Radosavljevic; Gazal Patnaik; Ekta Rishi; Francesco Pichi
Journal:  Ocul Immunol Inflamm       Date:  2020-11-02       Impact factor: 3.728

7.  Clinical spectrum and management options in Vogt-Koyanagi-Harada disease.

Authors:  Sikander Ak Lodhi; Jm Lokabhi Reddy; Venkataratnam Peram
Journal:  Clin Ophthalmol       Date:  2017-08-07

Review 8.  Association of human leukocyte antigen (HLA)-DQ and HLA-DQA1/DQB1 alleles with Vogt-Koyanagi-Harada disease: A systematic review and meta-analysis.

Authors:  Bing Liu; Tuo Deng; Linxin Zhu; Jingxiang Zhong
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.817

9.  Choroidal bulging in patients with Vogt-Koyanagi-Harada disease in the non-acute uveitic stage.

Authors:  Viviane M Sakata; Felipe T da Silva; Carlos E Hirata; Walter Y Takahashi; Rogerio A Costa; Joyce H Yamamoto
Journal:  J Ophthalmic Inflamm Infect       Date:  2014-02-18

10.  Unilateral Vogt-Koyanagi-Harada Disease: A Clinical Case Report.

Authors:  Arminda Neves; Ana Cardoso; Mariana Almeida; Joana Campos; António Campos; João Paulo Castro Sousa
Journal:  Case Rep Ophthalmol       Date:  2015-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.